FluoSphera proposes a new generation of multi-tissue test systems to Life Sciences laboratories and companies to better predict the effect of compounds (drugs, chemicals, pollutants, etc.) on human health. FluoSphera assays show an increased predictive power by mimicking the communications between the organs and tissues of the human body. Multi-tissue culture is now accessible to any laboratory thanks to our innovative products and service that rely on simple fluorescent codes.
Website: https://fluosphera.com
The team
Grégory Ségala
Co-founder, CEO & CSO
Ph.D. in Oncology
Marie Shamseddin
Co-founder & CTO
Ph.D. in Molecular Life Sciences
Sep 22, 2020